With three convenient locations and a team of fellowship-trained radiologists, MUSC Health is making it easier than ever for women to take control of their breast health, all backed by the state’s only NCI-designated cancer center.
At MUSC Hollings Cancer Center, our physicians and scientists are leading research in genomics to develop our most important cancer treatment. Yours.
Changing What's Possible
Our researchers are working daily to unlock the keys to cancer and develop new therapies to change what’s possible for cancer patients.
Behind every patient stands a multidisciplinary team of cancer specialists who work together to determine the best care plan for each patient.
The Hollings Cancer Center mobile health unit has supported our community with cancer screening, preventive health education and wellness counseling since 1998.
MUSC has been awarded with Magnet Recognition®,
an acknowledgment of quality patient care, and excellence and innovation in professional nursing practice.
Behind every patient stands a multidisciplinary team of cancer specialists who work together to determine the best care plan for each patient, and across our campus leading scientists and researchers work daily to unlock the clues to cancer.
Chanita Hughes-Halbert, Ph.D., is elected as one of 80 new members into the National Academy of Medicine, which is recognized as one of the highest honors in the fields of health and medicine. Dr. Hughes-Halbert is the first woman and first African-American from South Carolina to be elected to the Academy.
Hollings Cancer Center will be continuing the legacy of the Jerry Zucker Ride for Hope with an indoor group cycling class on November 5! Join world-class cyclist George Hincapie for a 45-minute ride while raising funds for cancer research. Riders can participate individually or as a team of four. Minimum fundraising goals are required, register online to ride today!
This year, more breakthroughs will be discovered. More cancer patients will find hope. And Hollings Cancer Center will be on the leading edge of offering better options to patients. As a cancer center that combines patient care and research, Hollings brings together over 180 physicians and scientists who are driving the discoveries that will lead to tomorrow’s treatments.
Quality & Awards
The only National Cancer Institute-Designated Cancer Center in South Carolina, Hollings is at the forefront of cancer research. This research is the driving force behind delivering medical advances to patients and their families, enabling us to educate health care professionals and the public, and to establish outreach services for underserved populations.
- Senator Ernest "Fritz" HollingsHollings in the Headlines
MUSC taking part in cutting edge cancer researchHollings in the Community
As one of the leading cancer treatment centers in the Southeast, Hollings Cancer Center combines the full range of cancer specialties to deliver a higher level of care to the patients we serve. Our team of more than 60 sub-specialists – each concentrating on a specific discipline of cancer treatment and care – works with individual patients to develop customized treatment programs that target a broad range of conditions. Our specialists work together as a team, often meeting with patients under the same roof on the same day. We are striving to deliver the highest level of care in the best way possible.
Personalized patient care is at the center of everything we do. And no one tells the story better than our patients themselves. Meet some of our patients and hear about their cancer journey.
Patients may be referred to Hollings by calling MEDULINE at 843-792-2200 or 800-922-5250, MUSC’s dedicated consultation line open 24/7 exclusively for health care professionals or through the online Patient Referral Portal.
Find a Nurse Navigator
Hollings Cancer Center is home to more than 120 scientists conducting research and collaborating on better ways to prevent, detect, diagnose and treat this complex disease. As one of 69 National Cancer Institute-Designated Cancer Centers, Hollings continues to attract top cancer researchers from leading institutions across the country who are conducting research in the community, laboratory and clinic.